FDA approves first AI tool to predict breast cancer risk

FDA approves first AI tool to predict breast cancer risk

Artificial intelligence uses mammograms to provide five-year risk scores for early detection

Clairity Breast has received FDA authorization for an AI tool that predicts breast cancer risk through mammograms. (iStock)

Mammograms have been an essential part of breast cancer detection for decades. (iStock)

"Advancements in AI and computer vision can uncover hidden clues in the mammograms," stated the founder of Clairity. (iStock)

Younger women are being diagnosed with breast cancer more frequently, data shows. (iStock)